FdaApplication
ANDA 091001
Identifiers
- fda_app_no: ANDA091001
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2011-01-26 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NISOLDIPINE | NISOLDIPINE | 8.5MG | TABLET, EXTENDED RELEASE;ORAL |
| NISOLDIPINE | NISOLDIPINE | 17MG | TABLET, EXTENDED RELEASE;ORAL |
| NISOLDIPINE | NISOLDIPINE | 34MG | TABLET, EXTENDED RELEASE;ORAL |
| NISOLDIPINE | NISOLDIPINE | 25.5MG | TABLET, EXTENDED RELEASE;ORAL |
4 products